291 related articles for article (PubMed ID: 18812760)
1. Subconjunctival bevacizumab for corneal neovascularization.
Doctor PP; Bhat PV; Foster CS
Cornea; 2008 Oct; 27(9):992-5. PubMed ID: 18812760
[TBL] [Abstract][Full Text] [Related]
2. Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization.
Yeung SN; Lichtinger A; Kim P; Amiran MD; Slomovic AR
Cornea; 2011 Oct; 30(10):1110-4. PubMed ID: 21673570
[TBL] [Abstract][Full Text] [Related]
3. Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study.
Benayoun Y; Adenis JP; Casse G; Forte R; Robert PY
Cornea; 2012 Aug; 31(8):937-44. PubMed ID: 22357391
[TBL] [Abstract][Full Text] [Related]
4. [Subconjunctival bevacizumab for corneal neovascularization].
Gueudry J; Richez F; Tougeron-Brousseau B; Genevois O; Muraine M
J Fr Ophtalmol; 2010 Nov; 33(9):630-6. PubMed ID: 21035899
[TBL] [Abstract][Full Text] [Related]
5. Subconjunctival bevacizumab for corneal neovascularization.
Zaki AA; Farid SF
Acta Ophthalmol; 2010 Dec; 88(8):868-71. PubMed ID: 19519730
[TBL] [Abstract][Full Text] [Related]
6. Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization.
Qian CX; Bahar I; Levinger E; Rootman D
Cornea; 2008 Oct; 27(9):1090-2. PubMed ID: 18812781
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization.
You IC; Kang IS; Lee SH; Yoon KC
Acta Ophthalmol; 2009 Sep; 87(6):653-8. PubMed ID: 19021596
[TBL] [Abstract][Full Text] [Related]
8. Subconjunctival bevacizumab for vascularized rejected corneal grafts.
Awadein A
J Cataract Refract Surg; 2007 Nov; 33(11):1991-3. PubMed ID: 17964413
[TBL] [Abstract][Full Text] [Related]
9. Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.
Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
Curr Eye Res; 2008 Jan; 33(1):23-8. PubMed ID: 18214740
[TBL] [Abstract][Full Text] [Related]
10. Subconjunctival bevacizumab injection for corneal neovascularization.
Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
Cornea; 2008 Feb; 27(2):142-7. PubMed ID: 18216566
[TBL] [Abstract][Full Text] [Related]
11. Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs.
Hurmeric V; Mumcuoglu T; Erdurman C; Kurt B; Dagli O; Durukan AH
Cornea; 2008 Apr; 27(3):357-62. PubMed ID: 18362668
[TBL] [Abstract][Full Text] [Related]
12. Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy.
Oh JY; Kim MK; Wee WR
Cornea; 2009 Oct; 28(9):1070-3. PubMed ID: 19724199
[TBL] [Abstract][Full Text] [Related]
13. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
[TBL] [Abstract][Full Text] [Related]
14. Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition.
Chu HS; Hu FR; Yang CM; Yeh PT; Chen YM; Hou YC; Chen WL
Cornea; 2011 Jan; 30(1):60-6. PubMed ID: 20847676
[TBL] [Abstract][Full Text] [Related]
15. Subconjunctival bevacizumab for corneal neovascularization.
Erdurmus M; Totan Y
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1577-9. PubMed ID: 17458556
[TBL] [Abstract][Full Text] [Related]
16. Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model.
Avisar I; Weinberger D; Kremer I
Curr Eye Res; 2010 Feb; 35(2):108-15. PubMed ID: 20136420
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
Kim TI; Kim SW; Kim S; Kim T; Kim EK
Cornea; 2008 Apr; 27(3):349-52. PubMed ID: 18362666
[TBL] [Abstract][Full Text] [Related]
18. Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats.
Hashemian MN; Moghimi S; Kiumehr S; Riazi M; Amoli FA
Ophthalmic Res; 2009; 42(2):90-5. PubMed ID: 19546599
[TBL] [Abstract][Full Text] [Related]
19. Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis.
Carrasco MA
Cornea; 2008 Jul; 27(6):743-5. PubMed ID: 18580272
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.
Papathanassiou M; Theodossiadis PG; Liarakos VS; Rouvas A; Giamarellos-Bourboulis EJ; Vergados IA
Am J Ophthalmol; 2008 Mar; 145(3):424-431. PubMed ID: 18207123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
